Characterization of disease course and remission in early seropositive rheumatoid arthritis: Results from the TACERA longitudinal cohort study
RA-MAP Consortium, Brian Tom
doi: https://doi.org/10.1101/2020.03.08.20028142
1United Kingdom
Brian Tom
2MRC Biostatistics Unit, University of Cambridge, United Kingdom

Data Availability
Data are available through the RA-MAP Sample and Data Access Committee. Contact: Dr Dennis Lendrem (dennis.lendrem{at}ncl.ac.uk)
Posted March 12, 2020.
Characterization of disease course and remission in early seropositive rheumatoid arthritis: Results from the TACERA longitudinal cohort study
RA-MAP Consortium, Brian Tom
medRxiv 2020.03.08.20028142; doi: https://doi.org/10.1101/2020.03.08.20028142
Subject Area
Subject Areas
- Addiction Medicine (175)
- Allergy and Immunology (423)
- Anesthesia (97)
- Cardiovascular Medicine (902)
- Dermatology (102)
- Emergency Medicine (257)
- Epidemiology (8810)
- Gastroenterology (405)
- Genetic and Genomic Medicine (1871)
- Geriatric Medicine (179)
- Health Economics (389)
- Health Informatics (1294)
- Health Policy (644)
- Hematology (207)
- HIV/AIDS (397)
- Medical Education (193)
- Medical Ethics (52)
- Nephrology (218)
- Neurology (1770)
- Nursing (105)
- Nutrition (267)
- Oncology (968)
- Ophthalmology (285)
- Orthopedics (107)
- Otolaryngology (177)
- Pain Medicine (118)
- Palliative Medicine (43)
- Pathology (265)
- Pediatrics (560)
- Primary Care Research (221)
- Public and Global Health (3998)
- Radiology and Imaging (657)
- Respiratory Medicine (538)
- Rheumatology (216)
- Sports Medicine (167)
- Surgery (199)
- Toxicology (37)
- Transplantation (107)
- Urology (80)